ACRS   $3.87  -10.42% Market Closed After Close 4.01 3.62%

Aclaris Therapeutics Inc
Total Cash 111.09M
totalCashPerShare 1.557
EBITDA -82.15M
Total Debt 2.82M
quickRatio 7.105
currentRatio 7.501
Total Revenue 32.02M
debtToEquity 2.104
Revenue/Share 0.451
ROA -0.25957
ROE -0.37425998
grossProfits
freeCashflow -39.52M
operatingCashflow -64.45M
earningsGrowth
revenueGrowth 0.48
grossMargins -1.7329401
ebitdaMargins -2.56595
operatingMargins -4.57484
profitMargins -1.83286
enterpriseValue 50.11M
forwardPE -3.53125
floatShares 55.20M
sharesOutstanding 71.34M
sharesShort 1.39M
sharesShortPriorMonth 1.71M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.78%
Short Ratio help_outline 5.23%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 1.876
Price To Book help_outline 1.20
earningsQuarterlyGrowth
netIncomeToCommon -58.68M
trailingEps -0.82%
forwardEps -0.64%
enterpriseToEbitda -0.61
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.01 3Q 2024
institutionsCount 121
lastUpdated Nov. 7, 2024, 2:02 a.m.